Abstract: The invention relates to methods for treating and preventing radiation and/or chemotherapy related injury and/or afflictions, such as myelosuppression and decreased macrophage activity, by administering a prophylactically or therapeutically effective amount of particulate, bioavailable ?(1,3; 1,6) glucan. The invention also relates to methods in which ?(1,3; 1,6) glucan is provided in the form of whole glucan particles, microparticulate ?-glucan particles or a combination thereof.
Type:
Application
Filed:
July 8, 2008
Publication date:
June 25, 2009
Applicants:
Biopolymer Engineering, University of Louisville Research Foundation, Inc.
Inventors:
Gary R. Ostroff, Gordon D. Ross, Trunetta Jo Dockter Ross